0001529224-21-000004.txt : 20211007
0001529224-21-000004.hdr.sgml : 20211007
20211007164040
ACCESSION NUMBER: 0001529224-21-000004
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20211007
DATE AS OF CHANGE: 20211007
EFFECTIVENESS DATE: 20211007
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: GeneCentric Therapeutics, Inc.
CENTRAL INDEX KEY: 0001529224
IRS NUMBER: 452540158
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-416162
FILM NUMBER: 211312797
BUSINESS ADDRESS:
STREET 1: 100 CAPITOLA DRIVE
STREET 2: SUITE 275
CITY: DURHAM
STATE: NC
ZIP: 27713
BUSINESS PHONE: (919) 973-6544
MAIL ADDRESS:
STREET 1: 100 CAPITOLA DRIVE
STREET 2: SUITE 275
CITY: DURHAM
STATE: NC
ZIP: 27713
FORMER COMPANY:
FORMER CONFORMED NAME: GeneCentric Diagnostics, Inc.
DATE OF NAME CHANGE: 20110902
D
1
primary_doc.xml
X0708
D
LIVE
0001529224
GeneCentric Therapeutics, Inc.
100 CAPITOLA DRIVE
SUITE 275
DURHAM
NC
NORTH CAROLINA
27713
(919) 973-6544
DELAWARE
GeneCentric Diagnostics, Inc.
Corporation
true
Michael
V.
Milburn
100 Capitola Drive
Suite 275
Durham
NC
NORTH CAROLINA
27713
Executive Officer
Director
Myla
V.
Lai-Goldman
100 Capitola Drive
Suite 275
Durham
NC
NORTH CAROLINA
27713
Executive Officer
Director
Clay
V.
Thorp
100 Capitola Drive
Suite 275
Durham
NC
NORTH CAROLINA
27713
Director
Perou
V.
Charles
100 Capitola Drive
Suite 275
Durham
NC
NORTH CAROLINA
27713
Executive Officer
Director
Arnold
V.
Levine
100 Capitola Drive
Suite 275
Durham
NC
NORTH CAROLINA
27713
Director
Ellen
V.
Lubman
100 Capitola Drive
Suite 275
Durham
NC
NORTH CAROLINA
27713
Director
Biotechnology
Decline to Disclose
- 06b
false
2021-09-22
false
true
false
0
7500000
4500000
3000000
false
1
0
0
0
false
GeneCentric Therapeutics, Inc.
/s/ Michael V. Milburn
Michael V. Milburn
President and CEO
2021-10-04